Table: Mochida Pharm -2024/25 parent results
May 12 (Reuters)-
Mochida Pharmaceutical Co Ltd
PARENT-ONLY FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
Year ended Year ended Year to NEXT
Mar 31, 2025 Mar 31, 2024 Mar 31, 2026 YEAR
LATEST YEAR-AGO COMPANY COMPANY
RESULTS RESULTS FORECAST H1 FORECAST
Sales 95.41 94.24
(+1.2 pct) (-1.3 pct)
Operating 5.48 3.22
(+70.2 pct) (-49.8 pct)
Recurring 7.57 5.36
(+41.4 pct) (-40.3 pct)
Net 5.38 4.67
(+15.2 pct) (-35.6 pct)
EPS 151.87 yen 130.27 yen
Ann Div 80.00 yen 80.00 yen 80.00 yen
-Q2 Div 40.00 yen 40.00 yen 40.00 yen
-Q4 Div 40.00 yen 40.00 yen 40.00 yen
NOTE - Mochida Pharmaceutical Co Ltd.
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4534.T